Experienced hands on life sciences finance executive and CPA offering interim CFO, Controller, and senior level financial project consulting nationally, specializing in the biotech, diagnostics and pharmaceutical industry. Expertise in all areas of finance from start up through multi-billion in revenue, public and privately-owned companies. High-integrity, common sense interim senior level finance support from hands-on to large financial organizations including all aspects of financial operations, revenue management, third party billing and collections, treasury, cash forecasting, accounting, external SEC and management reporting, budgeting, capital raising, investor relations, mergers and acquisitions, auditor relations, division finance leadership, and ongoing financial support. Experience in working with both venture and public company Boards and audit committees. Interim CEO, COO, President in health care diagnostic or biotech setting.

CFO for private equity-owned physician-directed, independent pathology laboratory specializing in Dermatopathology, urology, cytology, and oral pathology services.Implemented cash flow, budgeting, financial reporting structure, and revenue analysis tools to manage tight collection and capital environment and to focus on management accountability. Implemented controls over billing, collections, pricing, and revenue significantly improving compliance with regulatory requirements. Cost savings activities included vendor negotiations, targeted staff and infrastructure rationalization, facility elimination, equipment capacity improvements, bad debt reductionThe company was sold to Dermatopathology Experts, LLC in October 2015.

VP Operations for HealthTronics Lab Solutions division of Endo Pharmaceuticals. Responsible for reference laboratory and remote laboratory operations for urology laboratory business and facilities, along with oversight of key financial performance activitiesCost savings implementation included facility lease negotiation, quality control improvements, staff and facility rationalization

Responsible for all areas of finance, including financial reporting and systems, fundraising, financial modeling and forecasting, treasury management, audit relations, share option management and accounting, human resources, billing strategy and financial systems for this venture capital-funded biotechnology start up developing novel flow cytometry-based cancer laboratory testing. Successfully raised capital at solid valuations in very tough funding market.

CFO, Corporate Officer, and Corporate Secretary for $60 million Nasdaq-listed anatomic pathology laboratory. Responsible for all areas of finance, legal, billing, and investor relations.Cost savings included implementing productivity tools, product expansion focus, sale of non-strategic assets. Led implementation of in-source billing strategy.

CFO for $450 million division of $2.5 billion NYSE-listed global manufacturing and engineering conglomerate. Responsible for all aspects of finance, including financial reporting, budgeting, forecasting, strategic planning, and driving this global business in support of the division President.Corporate Controller and CAO for $2.5 billion, NYSE-listed manufacturing and engineering conglomerate. Responsible for SEC reporting, corporate consolidation, financial reporting, budgeting and forecasting. Led first Sarbanes-Oxley implementation efforts for large, de-centralized organization.

CFO for publicly traded, NASDAQ-listed $160MM+ sales science-based health care services company. Responsible for all areas of finance and administration, including SEC Reporting, Treasury, Billing, budgeting, purchasing, payroll, taxes, audit relationship as well as Information Technology and Investor Relations. Key member of senior management in developing evolving business strategy and message to public markets.Improved revenue recognition approach, discovered previous management reporting irregularities and managed through impact on the business

CFO for NASDAQ-listed media and technology company. Led all areas of finance and administration, including SEC Reporting, Treasury, Investor Relations, Human Resources, Pricing and Sales Administration, budgeting, cost analysis, purchasing, facilities, and manufacturing planning for this fast growing business-to-business technology company

Corporate officer for $1.5 Billion subsidiary of SmithKline Beecham Corporation. Led Financial Reporting, Corporate Accounting, Financial Systems, Tax, Internal Audit, Shared Services, Cost Accounting, Legal Analysis, business development analysis, acquisition due diligence, and Payroll. Established financial support area for International Operations and served on Mexico JV Board of Directors.